AlloCSC-02

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameAlloCSC-02
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCoretherapix Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTigenix Nv
Active IndicationsN/A
Inactive IndicationsCardiomyopathies

Other Information

ATC CodeN/A
Related LinksN/A